News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 31 Jul 2025Immunology & inflammation R&D trends and breakthrough innovations Providing scientific decision-makers with a roadmap of high-impact I&I opportunities, emerging technologies, and potential future partners. July 31, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 18 top French biotech companies! June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 6 May 2025 The future of diabetes treatment: Is a cure possible? Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we? May 6, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2025 Can GLP-1 agonists help treat addiction? Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders. March 14, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Jan 2025 Ten drugs to watch in 2025: will these therapies become blockbusters? Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate’s latest report. January 8, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Sublin Therapeutics 1 Oct 2024 Sublingual delivery: the future for GLP-1 receptor agonists Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method. October 1, 2024 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 25 Sep 2024 How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s. September 25, 2024 - 9 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
News and Trends 28 Aug 2024 GLP-1 shortage: Can biotech companies keep up with rising demand? How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question. August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 14 Jun 2024Looking to cure type 1 diabetes with precision medicine Listen to our conversation with Diamyd Medical, working on precision medicine therapies for the prevention and treatment of type 1 diabetes. June 14, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 18 Jan 2024 GLP-1 agonists: what’s the hype about? GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs. January 18, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Jan 2024 Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases? Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases. January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email